Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal dexmedetomidine PK/PD pilot study for PICC placement in preterm infants
2021-000801-25Phase 2Completed
- Sponsor
- IRCCS Burlo Garofolo
- Start
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of dexmedetomidine, sponsored by IRCCS Burlo Garofolo. Primary endpoint: Pharmacokinetics of intranasal dexmedetomidine. Started Oct 2021; status: completed.
02
Drugs
dexmedetomidine
Beyond the preview
Go deeper on 2021-000801-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-000801-25.